David has a passion for hospital pharmacy, compounding and the application of information technology to make life easier for pharmacists – and produce better patient outcomes. His deep understanding of the healthcare industry not only underpins the 55-year-old Slade Pharmacy business, but has been integral to the evolution of Slade Health.
Since founding the Slade Health compounding arm in 2012, David has driven acquisitions in the chemotherapy compounding space to evolve Slade Health into one of Australia’s largest oncology manufacturers. Since Slade’s incorporation into Icon Group, the compounding division has grown by over 300 percent and has secured contracts to deliver all public chemotherapy products across several states in Australia.
David is passionate about innovation and using technology to improve business operational capability. Slade was the first in Australia to introduce robotic dispensing technology into hospital pharmacy, develop and deploy an online ordering system for chemotherapy and use unique barcoding technology to support patient safety in hospitals.